financetom
Business
financetom
/
Business
/
Integral Ad Science Q2 revenue up 16%, beats estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Integral Ad Science Q2 revenue up 16%, beats estimates
Aug 7, 2025 2:28 PM

Overview

* IAS Q2 revenue rises 16% to $149.2 mln, beating analyst expectations, per LSEG data

* Adjusted EBITDA for Q2 beats estimates, reaching $51.6 mln at a 35% margin

* Company raises full-year financial outlook on strong Q2 results

Outlook

* IAS raises full-year 2025 revenue outlook to $597 mln-$605 mln

* IAS expects Q3 2025 revenue of $148 mln-$150 mln

* IAS sees full-year 2025 adjusted EBITDA at $208 mln-$214 mln

* IAS projects Q3 2025 adjusted EBITDA of $51 mln-$53 mln

Result Drivers

* AI-POWERED PRODUCTS - Strong adoption of AI-powered products drove revenue growth across all business segments, per CEO Lisa Utzschneider

* INNOVATIVE SOLUTIONS - Co attributes performance to solutions that enhance efficiency and ROI across diverse channels and markets

* PUBLISHER REVENUE - Publisher revenue surged 36% due to increased demand, contributing significantly to overall revenue growth

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $149.20 $143.20

Revenue mln mln (14

Analysts

)

Q2 Net $16.41

Income mln

Q2 Beat $51.60 $46.50

Adjusted mln mln (13

EBITDA Analysts

)

Q2 Gross 77.0%

Margin

Q2 Basic $0.1

EPS

Q2 $20.95

Operatin mln

g Income

Q2 $21.11

Pretax mln

Profit

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the advertising & marketing peer group is "buy"

* Wall Street's median 12-month price target for Integral Ad Science Holding Corp ( IAS ) is $13.00, about 37.9% above its August 6 closing price of $8.07

* The stock recently traded at 25 times the next 12-month earnings vs. a P/E of 22 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eledon Pharmaceuticals Says Tegoprubart Used in Kidney Transplant From Pig to Human
Eledon Pharmaceuticals Says Tegoprubart Used in Kidney Transplant From Pig to Human
Mar 21, 2024
02:18 PM EDT, 03/21/2024 (MT Newswires) -- Eledon Pharmaceuticals ( ELDN ) said Thursday its tegoprubart was used as a part of the immunosuppressive treatment regimen after a kidney transplant from a genetically modified pig to a 62-year-old man living with end-stage kidney disease. The company previously said that tegoprubart, as part of an immunosuppressive regimen, successfully prevented rejection based...
Mexican bottler Arca boosts investments to $1 billion in 2024
Mexican bottler Arca boosts investments to $1 billion in 2024
Mar 21, 2024
MEXICO CITY, March 21 (Reuters) - Mexican bottler Arca Continental said on Thursday that it plans to hike its investments by 32% year-over-year to 17 billion pesos ($1.02 billion), looking to solidify its operations across markets. Arca, Latin America's second-largest Coca-Cola bottler, will spend just over half of those funds in Mexico, its largest market. The remaining 45% of the...
Apollo Global Management Unusual Options Activity
Apollo Global Management Unusual Options Activity
Mar 21, 2024
Deep-pocketed investors have adopted a bullish approach towards Apollo Global Management ( APO ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in APO usually suggests something big is about to happen. We gleaned this...
CIBC FICC Strategy Note On BoC Deputy Governor Gravelle's Speech: Ending QT Early
CIBC FICC Strategy Note On BoC Deputy Governor Gravelle's Speech: Ending QT Early
Mar 21, 2024
02:20 PM EDT, 03/21/2024 (MT Newswires) -- Having gone through the speech delivered earlier Thursday by Bank of Canada Deputy Governor Gravelle, Ian Pollick, Managing Director & Head, FICC Strategy (Fixed Income, Currency & Commodities) at CIBC Capital Markets, has outlined the finer details. Pollick said: The Bank of Canada continues to suggest they will be using a floor system...
Copyright 2023-2026 - www.financetom.com All Rights Reserved